Actithera Norway AS
Latest round
- Series A
Last raised
- Jul 2025
Total raised
- $75M
Investors
- 9
About Actithera Norway AS
Founded in 2021 and headquartered in Paris, France, Actithera Norway AS specializes in radioligand therapy for cancer treatment.Actithera specializes in advanced cancer treatment through its innovative radioligand therapy (RLT) offerings. The company employs proprietary molecular design techniques to create best-in-class compounds that specifically target tumors while minimizing exposure to healthy tissues. This personalization of therapy is achieved by initially imaging patients to determine the appropriate treatment based on tracer uptake. Actithera's RLT products are designed to be more effective and better tolerated than traditional cancer therapies, significantly enhancing the quality of life for patients.Actithera's revenue model is primarily structured around partnerships and collaborations within the healthcare sector, specifically targeting hospitals and oncology clinics that administer their radioligand therapies. The company may engage in direct sales of its products to these institutions, which are expected to include flagship therapies designed for various types of cancers. Transactions are likely governed by negotiated pricing agreements tailored to the specific needs of healthcare providers, enabling volume purchases that can lead to cost efficiencies. The company aims to launch upcoming products designed for various cancer types while targeting expansion into North American, European, and parts of Asian markets by 2026.
Who invested in Actithera Norway AS
9 investors across 2 rounds
See all investors in Actithera Norway AS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Actithera Norway AS
Who invested in Actithera Norway AS?
Actithera Norway AS has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Actithera Norway AS raised?
Actithera Norway AS has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Actithera Norway AS last raise money?
Actithera Norway AS's most recent round on record is a Series A, in Jul 2025.
What does Actithera Norway AS do?
Founded in 2021 and headquartered in Paris, France, Actithera Norway AS specializes in radioligand therapy for cancer treatment.
Where is Actithera Norway AS headquartered?
Actithera Norway AS is headquartered in Oslo, Norway.
Which VCs invest in companies like Actithera Norway AS?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Actithera Norway AS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Actithera Norway AS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.